The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 350:1351-1352 March 25, 2004 Number 13
NextNext

Two Fillips for Human Embryonic Stem Cells
Elizabeth G. Phimister, Ph.D., and Jeffrey M. Drazen, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Cowan, C. A.
-PubMed Citation
EDITOR'S NOTE: The scientific report by Hwang et al.1 that is described in this article was retracted by Science on January 12, 2006. See Snyder and Loring (N Engl J Med 2006; 354:321-4) for further information.

Although there has been a lot of debate about the use of human embryonic stem cells, there has been little action until very recently, when a group from South Korea described the derivation of human embryonic stem cells obtained from a cloned blastocyst.1 This represents a significant step toward the cure of diseases that involve the loss of a particular cell type — diseases . . . [Full Text of this Article]


Source Information

This editorial was published at www.nejm.org on March 3, 2004.


This article has been cited by other articles:


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.